The National Cancer Institute clinical trials planning meeting to address gaps in observational and intervention trials for cancer-related cognitive impairment.
Saved in:
| Title: | The National Cancer Institute clinical trials planning meeting to address gaps in observational and intervention trials for cancer-related cognitive impairment. |
|---|---|
| Authors: | Janelsins MC; Division of Supportive Care in Cancer, Department of Surgery, University of Rochester Medical Center, Wilmot Cancer Institute, Rochester, NY, USA., Van Dyk K; Department of Psychiatry, David Geffen Scholl of Medicine, Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, CA, USA., Hartman SJ; Herbert Wertheim School of Public Health and Human Longevity Science, University of California, San Diego, San Diego, CA, USA., Koll TT; Division of Geriatrics, Gerontology and Palliative Medicine, Department of Medicine, University of Nebraska Medical Center, Omaha, NE, USA., Cramer CK; Department of Radiation Oncology, Wake Forest University School of Medicine, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA., Lesser GJ; Department of Internal Medicine, Section on Hematology and Oncology, Wake Forest University School of Medicine, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA., Barton DL; College of Nursing, University of Tennessee, Knoxville, Knoxville, TN, USA., Mustian KM; Division of Supportive Care in Cancer, Department of Surgery, University of Rochester Medical Center, Wilmot Cancer Institute, Rochester, NY, USA., Wagner LI; Department of Health Policy and Management, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Ganz PA; Fielding School of Public Health, University of California Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA., Cole PD; Department of Pediatric Hematology / Oncology, Rutgers Cancer Institute, Princeton, NJ, USA., Bakos A; National Cancer Institute, Bethesda, MD, USA., Root JC; Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Institute, New York, NY, USA., Hardy K; Division of Clinical Research, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA., Magnuson A; Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, Wilmot Cancer Institute, Rochester, NY, USA., Ferguson RJ; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., McDonald BC; Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA., Saykin AJ; Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA., Gonzalez BD; Moffitt Cancer Center, Tampa, FL, USA., Wefel JS; Department of Neuro-Oncology, MD Anderson Cancer Center, Houston, TX, USA., Morilak DA; University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Dahiya S; Division of Internal Medicine, Stanford University, Palo Alto, CA, USA., Heijnen CJ; Department of Psychological Sciences, Rice University, Houston, TX, USA., Conley YP; School of Nursing, University of Pittsburgh, Pittsburgh, PA, USA., Morgans AK; Department of Medicine, Dana Farber Cancer Institute, Boston, MA, USA., Mabbott D; Neurosciences and Mental Health Program, Hospital for Sick Children, Toronto, ON, Canada., Monje M; Department of Pediatric Neuro-Oncology, Stanford University, Palo Alto, CA, USA., Rapp SR; Department of Psychiatry and Behavioral Medicine, Wake Forest University School of Medicine, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA., Gondi V; Department of Radiation Oncology, Northwestern Medicine, Chicago, IL, USA., Bender C; School of Nursing, University of Pittsburgh, Pittsburgh, PA, USA., Embry L; University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., McCaskill Stevens W; National Cancer Institute, Bethesda, MD, USA., Hopkins JO; Southeast Clinical Oncology Research Consortium, Winston-Salem, NC, USA., St Germain D; National Cancer Institute, Bethesda, MD, USA., Dorsey SG; Pain and Translational Symptom Science Department, University of Maryland, Baltimore, Baltimore, MD, USA. |
| Source: | Journal of the National Cancer Institute [J Natl Cancer Inst] 2025 Feb 01; Vol. 117 (2), pp. 217-228. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1460-2105 |
|---|---|
| DOI: | 10.1093/jnci/djae209 |
